Prevagen® is Recognized as Safe and Effective in Vitamin Retailer National Publication
Madison, WI (PRWEB) May 29, 2014 -- Prevagen®, created by fast-growing company Quincy Bioscience, is recognized in Vitamin Retailer for being safe and effective. The article promotes the benefits of Prevagen’s memory-enhancing ingredient apoaequorin.
Vitamin Retailer is recognized as the dietary supplement industry's leading business magazine. Each issue published includes information regarding vitamins, minerals, herbs, specialty supplements, sports nutrition, and more. Vitamin Retailer reports that Prevagen supplements proteins in the brain that diminish in the natural process of aging, concluding, “Supplementing these proteins has shown to support brain cell function in laboratory studies and to improve memory in human clinical trials.”
The publication highlights the safety and effectiveness of Prevagen, revealing the outcomes of the clinical research studies. “Overall, participants in the experimental group (apoaequorin 10 mg) saw a significant change over the 90-day study period in the following areas: attention, visual learning, verbal learning, memory, delayed recall, and executive function,” Vitamin Retailer affirms. “The data suggests apoaequorin is a safe and potentially effective approach to help those who experience mild memory problems in aging.”
Backed with published safety and efficacy studies, Prevagen has helped hundreds of thousands of consumers through its distribution nationwide in drugstores, health food stores, and physician offices since the product was launched in 2007.
Read the digital edition of the publication here and find Prevagen on page 73.
About Quincy Bioscience:
Quincy Bioscience is a biotechnology company based in Madison, Wis. that focuses on the discovery, development and commercialization of novel technologies to support good health in aging. The company’s products focus on supporting memory and cognitive health. Quincy Bioscience is set apart by its cutting-edge applications of the protein apoaequorin, which is breaking new ground in the area of brain health.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Todd Olson, Quincy Bioscience, http://www.quincybioscience.com, 608-827-8134, [email protected]
Share this article